Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the mGluR5 Inhibitor Mavoglurant (clinicaltrials.gov) - Sep 25, 2026 - P1 | N=78 | Completed | Sponsor: Yale University | Recruiting ➔ Completed
Trial completion • Addiction (Opioid and Alcohol)
|